» Articles » PMID: 31867567

Nature's Derivative(s) As Alternative Anti-Alzheimer's Disease Treatments

Overview
Publisher IOS Press
Date 2019 Dec 24
PMID 31867567
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD), the 'Plague of Twenty-First Century,' is a crippling neurodegenerative disease that affects a majority of the older population globally. By 2050, the incidence of AD is expected to rise to 135 million, while no treatment(s) that can reverse or control the progression of AD are currently available. The treatment(s) in use are limited in their ability to manage the symptoms or slow the progression of the disease and can lead to some severe side effects. The overall care is economically burdensome for the affected individuals as well as the caretakers or family members. Thus, there is a pressing need to identify and develop much safer alternative therapies that can better manage AD. This review discusses a multitude of such treatments borrowed from Ayurveda, traditional Chinese practices, meditation, and exercising for AD treatment. These therapies are in practice since ancient times and reported to be beneficial as anti-AD therapies. Ayurvedic drugs like turmeric, , , etc., management of stress by meditation, regular exercising, and acupuncture have been reported to be efficient in their anti-AD usage. Besides, a combination of vitamins and natural dietary intakes is likely to play a significant role in combating AD. We conclude that the use of such alternative strategies will be a stepping-stone in preventing, treating, curing, or managing the disease.

Citing Articles

Pharmacological effects of herbal ingredients of Manasamitra vatakam in the treatment of Alzheimer's disease: A review.

Nair A, Briget Kuriakose B, Biju A, Surendran S, Sudheesh M, Lakshmi P J Ayurveda Integr Med. 2025; 16(1):101041.

PMID: 39799838 PMC: 11773069. DOI: 10.1016/j.jaim.2024.101041.


Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity.

Zhang L, Zhang H, Liu Y, Tang M, Jiang Y, Li F Neurochem Res. 2024; 49(6):1592-1602.

PMID: 38305960 DOI: 10.1007/s11064-024-04107-x.


The Potential of a Stratified Approach to Drug Repurposing in Alzheimer's Disease.

Anderson C, Bucholc M, McClean P, Zhang S Biomolecules. 2024; 14(1).

PMID: 38275752 PMC: 10813465. DOI: 10.3390/biom14010011.


The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer's Like Brain Changes on Severely SARS-CoV-2 Infected Patients.

Rahman M, Akter R, Neelotpol S, Mayesha I, Afrose A Am J Alzheimers Dis Other Demen. 2023; 38:15333175231214974.

PMID: 37972355 PMC: 10655662. DOI: 10.1177/15333175231214974.


American Ginseng for the Treatment of Alzheimer's Disease: A Review.

Shan M, Bai Y, Fang X, Lan X, Zhang Y, Cao Y Molecules. 2023; 28(15).

PMID: 37570686 PMC: 10420665. DOI: 10.3390/molecules28155716.


References
1.
Rai K, Murthy K, Karanth K, Nalini K, Rao M, Srinivasan K . Clitoria ternatea root extract enhances acetylcholine content in rat hippocampus. Fitoterapia. 2002; 73(7-8):685-9. DOI: 10.1016/s0367-326x(02)00249-6. View

2.
Bonavida B, Mencia-Huerta J . Platelet-activating factor and the cytokine network in inflammatory processes. Clin Rev Allergy. 1994; 12(4):381-95. DOI: 10.1007/BF02802301. View

3.
Canobbio I, Abubaker A, Visconte C, Torti M, Pula G . Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease. Front Cell Neurosci. 2015; 9:65. PMC: 4347625. DOI: 10.3389/fncel.2015.00065. View

4.
Wong A, Gasic-Milenkovic J, Schinzel R, Wiesinger H, Riederer P, Munch G . Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. Eur J Neurosci. 2002; 14(12):1961-7. DOI: 10.1046/j.0953-816x.2001.01820.x. View

5.
Schoels M, van der Heijde D, Breedveld F, Burmester G, Dougados M, Emery P . Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement. Ann Rheum Dis. 2012; 72(4):583-9. PMC: 3595140. DOI: 10.1136/annrheumdis-2012-202470. View